Apogee Therapeutics Funding & Investors
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.
apogeetherapeutics.comTotal Amount Raised: $652,000,000
Apogee Therapeutics Funding Rounds
Post Ipo Equity
$483,000,000
Series B
$149,000,000
Series B Investors
Deep Track CapitalRTW InvestmentsRa Capital ManagementFairmount Funds ManagementVenrock Healthcare Capital PartnersPerceptive AdvisorsOrbiMed AdvisorsWellington ManagementFidelity InvestmentsSeries A
$20,000,000
Series A Investors
Fairmount Funds ManagementVenrock Healthcare Capital Partners
Funding info provided by Diffbot.